15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 纤维化的慢性病毒性肝炎进展与IL-17 +嗜中性粒细胞相关 ...
查看: 461|回复: 1
go

纤维化的慢性病毒性肝炎进展与IL-17 +嗜中性粒细胞相关的 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2016-1-15 14:27 |只看该作者 |倒序浏览 |打印
Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17+ neutrophils

    Zuzana Macek Jilkova1,2,†, Samia Afzal1,3,†, Hélène Marche1,2, Thomas Decaens1,2,4, Nathalie Sturm1,2,5, Evelyne Jouvin-Marche1,2, Bertrand Huard1,2 andPatrice N Marche1,2,*

DOI: 10.1111/liv.13060

This article is protected by copyright. All rights reserved.

Issue
Cover image for Vol. 36 Issue 1
Liver International

Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)
Article has an altmetric score of 2

Additional Information(Show All)

Author Information
Publication History
Author Information

    1    Univ. Grenoble Alpes, IAB, Grenoble, France
    2    INSERM U823, Grenoble, France
    3    National Center of Excellence in Molecular Biology, University of The Punjab, Lahore, Pakistan
    4    CHU-Grenoble Département d'Hépato-Gastro-Entérologie, La Tronche
    5    CHU-Grenoble Département d'Anatomie et de Cytologie Pathologiques, La Tronche

    †    ZMJ and SA contributed equally to this work

* Correspondence: Patrice N Marche, Immunologie Analytique des Pathologies Chroniques, Institut Albert Bonniot, Centre de Recherche INSERM-UJF-U823, 38700 La Tronche,
Mail: [email protected], Phone: +33(0)476549495, Fax: +33(0)476549413.

    This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/liv.13060


Keywords:

    Liver;Fibrosis;Neutrophils;IL-17

Abstract
Background & Aims

The pro-inflammatory cytokine IL-17 plays a crucial role in liver diseases associated with hepatic fibrosis and increased risk of cancer development. Nevertheless, the cellular source of this cytokine has never been characterised in patients with liver fibrosis.
Methods

In this study, we investigated liver biopsies from 49 patients with chronic viral hepatitis at different stages of liver fibrosis. We monitored IL-17 production by intracellular flow cytometry, immunofluorescence and immunohistochemical in situ stainings, allowing a precise quantification, characterization, and localization of IL-17+ cells.
Results

Density of IL-17+ cells increased with the stage of liver fibrosis specifically in fibrotic septa and portal areas (correlation coefficient r = 0.7373; p<0.0001). Data clearly show that the frequency of intrahepatic IL-17+ lymphocytes (including T, NKT and NK cells) was independent on stage of liver fibrosis and we observed no statistical differences in number of IL-17+ macrophages during progression of fibrosis. On the other hand, the number of IL-17+ neutrophils in fibrotic septa and portal areas strongly correlated with the stages of fibrosis (correlation coefficient r = 0.6986; p<0.0001), contributing significantly to total IL-17 production in liver tissue.
Conclusions

Our data indicate that neutrophils represent an important source of IL-17 in the human liver, especially in late fibrosis stages. Inhibition of this specific harmful subset of neutrophils may offer therapeutic opportunities in fibrotic liver.

This article is protected by copyright. All rights reserved.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2016-1-15 14:28 |只看该作者
纤维化的慢性病毒性肝炎进展与IL-17 +嗜中性粒细胞相关的

    苏珊娜Macek Jilkova1,2,†,萨米亚Afzal1,3,†,海伦Marche1,2,托​​马斯Decaens1,2,4,纳塔莉Sturm1,2,5,伊夫琳Jouvin-Marche1,2,伯特兰Huard1,2 andPatriceñMarche1,2 *

DOI:10.1111 / liv.13060

这篇文章是受版权保护的。版权所有。

问题
封面图片卷。 36第1期
肝国际

接受第(接受,未编辑的文章在网上和可引用出版。最后编辑记录的排版本将出现在未来的。)
文章的altmetric比分2

其他信息(显示所有)

作者信息
出版历史
作者信息

    1大学。格勒诺布尔阿尔卑斯,IAB,法国格勒诺布尔
    2 INSERM U823,法国格勒诺布尔
    卓越的旁遮普大学3个国家级中心分子生物学,拉合尔,巴基斯坦
    4 CHU-格勒诺布尔DEPARTEMENT D'肝,胃Ent​​érologie,香格里拉Tronche
    5 CHU-格勒诺布尔DEPARTEMENT科特迪瓦Anatomie和de Cytologie Pathologiques,拉Tronche

    †郑煤机和SA同等贡献这项工作

*通讯:帕特里斯ñ马尔凯,Immunologie Analytique德病理学Chroniques,阿尔贝研究所Bonniot,中心去RECHERCHE INSERM-UJF-U823,38700的La Tronche,
邮件:[email protected],电话:+33(0)476549495,传真:+33(0)476549413。

    这篇文章已被接受发表,并经过充分的同行评审,但经过审稿,排版,分页和校对过程中,这可能会导致这个版本和记录的版本之间的差异还没有。请引用这篇文章的DOI:10.1111 / liv.13060


关键词:

    肝;纤维化;中性粒细胞; IL-17

抽象
背景和目的

促炎性细胞因子IL-17起着与肝纤维化和癌症发展的风险增加有关肝脏疾病至关重要的作用。然而,该细胞因子的细胞来源从未表征患者肝纤维化。
方法

在这项研究中,我们调查了肝活检49例慢性病毒性肝炎的肝纤维化的不同阶段。我们监测IL-17的生产通过细胞内流式细胞,免疫荧光和免疫组织化学原位染色,允许精确定量,鉴定和定位的IL-17 +细胞。
结果

IL-17 +细胞增多与肝纤维化的阶段,特别是在纤维间隔及汇管区的密度(相关系数r = 0.7373,P <0.0001)。数据清楚地表明,肝内的IL-17 +淋巴细胞(包括T,NKT细胞和NK细胞)的频率是独立于肝纤维化的阶段,我们观察到了IL-17 +巨噬细胞的数量没有统计学差异纤维化进展中。另一方面,IL-17 +嗜中性粒细胞与纤维化的阶段强烈相关纤维间隔和门区的数量(相关系数r = 0.6986; P <0.0001),肝组织中,以总的IL-17生产显著贡献。
结论

我们的数据表明,嗜中性粒细胞代表的IL-17的一个重要来源在人体肝脏,特别是在晚期纤维化阶段。嗜中性粒细胞的这一特定有害子集的抑制作用可能会提供肝纤维化的治疗机会​​。

这篇文章是受版权保护的。版权所有
已有 1 人评分现金 收起 理由
MP4 + 3

总评分: 现金 + 3   查看全部评分

‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-3 04:27 , Processed in 0.013153 second(s), 12 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.